New Share Buyback Programme

Summary by AI BETAClose X

B.P. Marsh & Partners Plc has launched a new share buy-back programme, replacing a previous one where approximately £0.3 million was spent on 47,000 ordinary shares. The new programme, managed by Singer Capital Markets under an irrevocable commitment, has a maximum aggregate consideration of £2 million and will operate within defined parameters, allowing repurchases on the open market. The company has the authority to purchase up to 3,710,000 ordinary shares, with this authority expiring on 31 July 2027. The purpose of the programme is to reduce the company's share capital, and B.P. Marsh confirms it has no unpublished price sensitive information.

Disclaimer*

B.P. Marsh & Partners PLC
15 July 2026
 

15 July 2026

 

B.P. Marsh & Partners Plc

("B.P. Marsh", the "Company" or the "Group")

 

New Share Buyback Programme

 

B.P. Marsh & Partners Plc (AIM:  BPM), the specialist private equity investor in early stage financial services businesses, today announces the launch of a new share buy-back programme (the "Programme"), replacing the buyback programme announced on 26 March 2026, pursuant to which 47,000 Ordinary Shares were repurchased for a total consideration of approximately £0.3 million and which terminated at the conclusion of the Company's annual general meeting on 8 July 2026 (the "AGM").

 

The Company has entered into an irrevocable commitment with Singer Capital Markets to manage the Programme through a non-discretionary programme, repurchasing the Company's Ordinary Shares on its behalf, for up to a maximum aggregate consideration of £2 million and within certain defined parameters. Singer Capital Markets will make trading decisions in relation to the buyback of Ordinary Shares independently of the Company within the programme terms and will therefore have the ability to trade during closed periods.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms.

 

The maximum price paid per Ordinary Share will be no more than the higher of (a) 105 per cent of the average of the middle market quotations for an Ordinary Share (as derived by the Daily Official List of the London Stock Exchange Daily official List) for the five business days immediately prior to the day on which the purchase is made and (b) the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out. Under the Programme, the repurchased shares will be held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Programme will operate in accordance with the Company's general authority to purchase a maximum of 3,710,000 Ordinary Shares (the "Authority"), granted by its shareholders at the AGM. This General Authority expires at the Company's next Annual General Meeting or, if earlier, at the close of business on 31 July 2027.

 

Shareholders should be aware that a purchase of Ordinary Shares by the Company on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares and could exceed 25 per cent. of the average daily trading volume of the preceding 20 business days. Should that be the case, the Company could exceed the pricing and/or volume restrictions as established by the Commission Delegated Regulation 2016/1052/EU (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) (the "Regulation") and therefore the Buyback may not fall within the safe harbour provisions of the Regulation.

 

The purpose of the Programme is to reduce the Company's share capital. The Company confirms that it currently has no unpublished price sensitive information.

 

The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by UK MAR and the AIM Rules.

 

For further information on B.P. Marsh, its strategy and current portfolio, please contact:

 

B.P. Marsh & Partners Plc

Daniel Topping / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh-Pemberton / Peter Steel / James Todd

 

+44 (0)20 7496 3000

Joint Corporate Broker:

Investec Bank plc

Christopher Baird / Maria Gomez de Olea/ Gordon Hamilton

 

+44 (0)20 7597 5970

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

 

About B.P. Marsh

B.P. Marsh & Partners Plc (AIM: BPM) is a specialist investor in early stage and small to medium-sized financial services intermediary businesses, with a particular focus on the insurance sector. Bridging the gap to traditional private equity funding rounds, B.P. Marsh takes a typical initial equity stake of up to £5m, often complemented by loans, and is able to tailor its investment model to each opportunity. Taking a long-term view of its investments, with an average holding period of around seven years, the Group supplies strategic insight and capital while empowering entrepreneurial management teams to grow their businesses.

 

The B.P. Marsh portfolio is diversified by geography and class of business, spanning insurance brokers, underwriting agencies and financial advisers in the UK, Europe, North America and other international markets. For further information, including details of the current portfolio and recent exits, please visit: www.bpmarsh.co.uk.

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings